AtaiBeckley is a biotech company that develops new treatments for mental health conditions. It focuses on fast-acting, effective and easy-to-use medicines for patients with difficult-to-treat disorders. The company was created in 2025 after the merger of atai Life Sciences and Beckley Psytech. It uses strong scientific research to develop safe and long-lasting therapies. Its main goal is to improve mental health care and help patients live better lives through new, evidence-based drug development and innovation in medicine.